Prices delayed by at least 15 minutes | Print
Eagle Pharmaceuticals (EGRX)
Common SharesThis share can be held in a Dealing accountISALifetime ISAJISASIPP
Company profile
Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.
Address
50 Tice Boulevard
Suite 315
Woodcliff Lake
NJ
USA
07677
Telephone
+1 201 326-5300
Forecast key dates
Name | Key Date |
---|---|
Eagle Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2024 | 2024-11-08T08:30:00 |
Eagle Pharmaceuticals Inc Third Quarter Earnings Result for 2024 | 2024-11-08T00:00:00 |
Eagle Pharmaceuticals Inc Second Quarter Earnings Conference Call for 2024 | 2024-08-08T08:30:00 |
Eagle Pharmaceuticals Inc Second Quarter Earnings Results for 2024 | 2024-08-08T00:00:00 |
Eagle Pharmaceuticals Inc Annual General Meeting for 2024 | 2024-06-28T10:00:00 |
Eagle Pharmaceuticals Inc Fourth Quarter Earnings Result for 2023 | 2024-05-10T00:00:00 |
Eagle Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2023 | 2024-05-10T00:00:00 |
Eagle Pharmaceuticals Inc First Quarter Earnings Conference Call for 2024 | 2024-05-09T08:30:00 |
Eagle Pharmaceuticals Inc First Quarter Earnings Results for 2024 | 2024-05-09T00:00:00 |
Eagle Pharmaceuticals Inc Annual Report for 2023 | 2024-05-06T00:00:00 |
Eagle Pharmaceuticals Announces a Trial in Progress Presentation of Phase 2 | 2024-05-02T00:00:00 |
Previous key dates
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.